308787
Insulin resistance associated with the intake of fructose-containing beverages among adolescents
Objectives: To evaluate the effect of FCB consumption on pediatric IR, we assessed data from 1454 representative adolescents who were multistage-sampled from 36 junior high schools in Taiwan.
Methods: Data assessments included demographic factors, dietary, physical activity, anthropometric and clinical measures. Survey-data modules were applied in all data, and multivariate regression and logistic models were used to controlling for potential confounders.
Results: Higher SSB consumption was associated with higher levels of body mass index (BMI), uric acid, original homeostasis model assessment of insulin resistance (HOMA1-IR), updated HOMA nonlinear computer model (HOMA2-IR), even participants with cardiovascular disease, hypertension or diabetes were excluded. Adjusted for BMI and covariates, heavy FCB drinkers had a 0.41and 0.23 higher level of HOMA1-IR and HOMA2-IR, respectively, than non-drinkers.
Conclusions: While type 2 diabetes does not become clinically apparent until the adulthood, our findings highlight the effect of high FCB consumption on IR among adolescents.
Learning Areas:
Administer health education strategies, interventions and programsAdvocacy for health and health education
Epidemiology
Planning of health education strategies, interventions, and programs
Public health biology
Public health or related education
Learning Objectives:
Evaluate the effect of Taiwanese style fructose-containing beverages consumption on pediatric Insulin resistance.
Keyword(s): Children and Adolescents, Diabetes
Qualified on the content I am responsible for because: I am a master student at Kaohsiung Medical University, department of Public Health. I am a student investigator in this research project that examined the relationship of adolescents metabolic syndrome and sugar-sweetened beverage. I am reasonable for
subject recruitment, data collection and data analysis.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.